Danaher Corp. (NYSE: DHR), Washington, DC, reported first-quarter sales of $4.7 billion, an 11.5 percent increase year-over-year. Profit rose 16 percent to $566.6 million.
The company credits the strong performance to mid-single digit or better growth in four of its five platforms, including 9.5 percent growth in its Diagnostics business.
Danaher recently closed the acquisition of Integrated DNA Technologies, Inc., announced during the first quarter.